Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Canada"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"140 - Specific philosophical schools"
product_txtF_mv:"National Center for Biotechnology Information"
Showing
1
-
20
of
41
Search:
'"Canada"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
2
Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
3
Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
4
Pharmacoeconomic review report: Burosumab (Crysvita), Kyowa Kirin Limited : indication : for the treatment of x-linked hypophosphatemia in adult and pediatric patients one year of...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
5
Clinical review report: Tocilizumab (Actemra) (Hoffmann-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
6
Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
7
Clinical review report: Burosumab (Crysvita) (Kyowa Kirin limited) : indication: for the treatment of x-linked hypophosphatemia in adult and pediatric patients one year of age and...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
8
Clinical review report: Tocilizumab (Actemra) (Hoffmann-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
9
Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
10
Sarilumab (Kevzara)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication : for the treatment of adult patients with moderately to severely acti...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
13
HPV testing for primary cervical cancer screening : recommendations report
Published 2019
CADTH
Subjects:
“
...
Canada
...
”
Read Now
14
CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
15
HPV testing for primary cervical cancer screening : recommendations report
Published 2019
CADTH
Subjects:
“
...
Canada
...
”
Read Now
16
Patient group input submissions: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
17
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
18
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
19
Patient group input submissions: Ixekizumab (Taltz) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or photothe...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
Read Now
20
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Canada
...
”
1
2
3
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 140 - Specific philosophical schools
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
330 - Economics
20
610 - Medicine & health
19
700 - The arts; fine & decorative arts
17
Language
English
41
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
38
CADTH Canadian Drug Expert Committee
14
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
3
Grobelna, Aleksandra
2
Wells, Charlotte
2
Argáez, Charlene
1
more ...
Marchand, Dave K.
1
Multiple Sclerosis Society of Canada
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22140+-+Specific+philosophical+schools%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&lookfor=%22Canada%22&type=Subject
Send by Email
×
Loading...